We are happy to share that eligible HAE patients across Canada who have coverage under the Non-Insured Health Benefits (NIHB) for First Nations and Inuit Program can now access lanadelumab (TAKHZYRO) as a limited use product. Please speak to your HAE specialist about accessing Takhzyro, and you can find details on the Express Scripts Canada website (the organization that administers NIHB claims), by simply typing lanadelumab into the “Chemical Name” field, and then click the “View Details” box.
Thank you!